Bandingkan Harga & Kinerja Fore Kopi Indonesia Tbk. (FORE) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Fore Kopi Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Fore Kopi Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 7,09 T, volume 24 jam 4,99 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Fore Kopi Indonesia Tbk. jauh lebih besar — sekitar 67,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| FORE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 7,09 T | 104,4 M |
Volume | 4,99 jt | — |
Lot | 49,86 rb | — |
Perputaran | 3,88 M | — |
Harga Rata-rata | 777,82 | — |
Nilai Transaksi | 3,88 M | — |
Harga Ekuilibrium Indikatif | 775 | — |
Volume Ekuilibrium Indikatif | 1,54 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Fore Kopi Indonesia Tbk.
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Selengkapnya di halaman FORE →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
